GR3036306T3 - Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology - Google Patents

Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology

Info

Publication number
GR3036306T3
GR3036306T3 GR20010401156T GR20010401156T GR3036306T3 GR 3036306 T3 GR3036306 T3 GR 3036306T3 GR 20010401156 T GR20010401156 T GR 20010401156T GR 20010401156 T GR20010401156 T GR 20010401156T GR 3036306 T3 GR3036306 T3 GR 3036306T3
Authority
GR
Greece
Prior art keywords
pharmaceutical agents
metal complexes
interventional radiology
tumour therapy
agents containing
Prior art date
Application number
GR20010401156T
Other languages
English (en)
Inventor
Johannes Platzek
Ulrich Niedballa
Bernd Raduechel
Wolfgang Schlecker
Hanns-Joachim Weinmann
Thomas Frenzel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of GR3036306T3 publication Critical patent/GR3036306T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/244Lanthanides; Compounds thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
GR20010401156T 1996-02-23 2001-07-31 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology GR3036306T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19608278A DE19608278A1 (de) 1996-02-23 1996-02-23 Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
PCT/EP1997/000684 WO1997030969A1 (de) 1996-02-23 1997-02-14 Pharmazeutische mittel enthaltend perfluoralkylhaltige metallkomplexe und ihre verwendung in der tumortherapie und interventionellen radiologie

Publications (1)

Publication Number Publication Date
GR3036306T3 true GR3036306T3 (en) 2001-10-31

Family

ID=7787153

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401156T GR3036306T3 (en) 1996-02-23 2001-07-31 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology

Country Status (14)

Country Link
EP (1) EP0882010B1 (el)
JP (1) JP2000504736A (el)
AT (1) ATE200894T1 (el)
AU (1) AU1769297A (el)
CA (1) CA2247253A1 (el)
DE (2) DE19608278A1 (el)
DK (1) DK0882010T3 (el)
ES (1) ES2158493T3 (el)
GR (1) GR3036306T3 (el)
NO (1) NO323547B1 (el)
PT (1) PT882010E (el)
TW (1) TW477699B (el)
WO (1) WO1997030969A1 (el)
ZA (1) ZA971537B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919433A (en) * 1996-12-04 1999-07-06 Schering Aktiengesellschaft Macrocyclic metal complex carboxylic acids, their use as well as process for their production
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19731591C2 (de) * 1997-07-17 1999-09-16 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
US6461587B1 (en) 1999-03-22 2002-10-08 Schering Aktiengesellschaft Perfluoroalkylamides, their production and their use in diagnosis
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
US6676928B2 (en) 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
WO2003013610A2 (en) * 2001-08-03 2003-02-20 Glaxo Group Limited Surfactant compounds and uses thereof
WO2004006934A2 (de) * 2002-07-10 2004-01-22 Hans Robert Kalbitzer 1,4,7,10-tetraazacyclododecane als modulatoren des guanin-nukleotid bindenden roteins zur behandlung von tumoren
DE102005008309A1 (de) * 2005-02-17 2006-08-24 Schering Ag Pharmazeutische Mittel enthaltend fluoralkylhaltige Metallkomplexe und Epothilone
ITMI20131225A1 (it) * 2013-07-22 2015-01-23 Miteni Spa Nuovi composti organici fluorurati, procedimento per la loro preparazione e loro uso come intermedi di sintesi
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
EP3544964B1 (en) 2016-11-28 2020-06-17 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
AU2019382881A1 (en) 2018-11-23 2021-05-20 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof
JP2024020674A (ja) * 2021-01-06 2024-02-15 Agc株式会社 ペプチド

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803869C2 (de) * 1978-01-30 1983-12-29 Ethicon, Inc., 08876 Somerville, N.J. Injizierbare Embolisations- und Okklusionslösung
JPS59130812A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JPS59130813A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JP2657393B2 (ja) * 1988-05-18 1997-09-24 日本化薬株式会社 化学塞栓療法剤
FR2682110B1 (fr) * 1991-10-02 1995-05-24 Atta Ligands amphiphiles perfluoroalkyles leurs complexes metalliques et leurs utilisations dans des preparations a usage therapeutique.
WO1993018795A1 (en) * 1992-03-19 1993-09-30 Daikin Industries, Ltd. Mri contrast medium and diagnostic method
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same

Also Published As

Publication number Publication date
DE19608278A1 (de) 1997-08-28
ES2158493T3 (es) 2001-09-01
NO323547B1 (no) 2007-06-11
PT882010E (pt) 2001-10-30
DK0882010T3 (da) 2001-08-20
EP0882010B1 (de) 2001-05-02
JP2000504736A (ja) 2000-04-18
NO983875D0 (no) 1998-08-21
NO983875L (no) 1998-10-22
ATE200894T1 (de) 2001-05-15
TW477699B (en) 2002-03-01
ZA971537B (en) 1997-10-30
DE59703468D1 (de) 2001-06-07
AU1769297A (en) 1997-09-10
WO1997030969A1 (de) 1997-08-28
CA2247253A1 (en) 1997-08-28
EP0882010A1 (de) 1998-12-09

Similar Documents

Publication Publication Date Title
GR3036306T3 (en) Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology
IL127352A0 (en) Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosupressives
HUP0303665A2 (hu) Káliumcsatorna-blokkoló hatású arilezett furán- és tiofén-karbonsavamidok
NO302078B1 (no) Utskillingsherdbar martensittisk rustfri stål-legering og anvendelse av denne
DK0641767T3 (da) Cytotoksiske stilbenderivater og farmaceutisk præparat indeholdende disse derivater
NO166267C (no) Konjugat av et maalsoekende biologisk aktivt molekyl og en forbindelse inneholdende spormerkende metall, samt diagnostisk preparat inneholdende konjugatet.
AU8623698A (en) Perfluoroalkylated oligomer compounds, process for preparing the same and their use in nmr diagnosis
KR910007858A (ko) 초기-촉진 및 향상된 진통제로서의 s(+)-이부프로펜-l-아미노산 및 s(+)-이부프로펜-d-아미노산
GR3025022T3 (en) 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
BR9814048A (pt) "misturas de enantiÈmetros de aminociclohexil amidas para produzir de modo simultâneo analgesia com anestesia local ou antiarritmia "
CS346491A3 (en) Complexes containing s-(+)-phenylalkanoic acids and alpha-amino acids
DE59811656D1 (en) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
PT876144E (pt) "agentes terapeuticos, contendo ebselen contra a asma"
IL112344A (en) Pharmaceutical compositions comprising 7, 9, 9-trisubstituted- 3-benzoyl-3, 7-diazabicyclo £3.3.1| nonanes for the treatment of cardiac arrhythmias
GR3023896T3 (en) 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof.
AU2049995A (en) Tumor affinity peptide, and radioactive diagnostic agent and adioactive therapeutic agent containing the peptide
CA2305764A1 (en) Bile acid salts of metals with physiological action and the use thereof in therapy
AU572374B2 (en) Azolyl-aroxymethyl-dimethylpentinols, their use as fungicides
EP0284069A3 (en) Benzopyranopyridineacetic acid ester compounds and their pharmaceutical uses
RU93038588A (ru) Сплав для получения низкокремнистого ферромарганца
Boreham Intramolecular Hydrolysis of Glycine Derivatives Coordinated to Cobalt (III) and Some Aspects of Iron Porphyrins Containing Attached Sulphur Groups
TH17660A (th) สารผสมสำหรับป้องกันและรักษาสายตาสั้น

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees